Alert systems for post‐marketing surveillance of adverse drug reactions
- 30 December 1993
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 12 (24) , 2383-2393
- https://doi.org/10.1002/sim.4780122414
Abstract
When monitoring spontaneous reports of adverse reactions to registered drugs, it is important to detect any change in the number of reported adverse reactions in the course of time. Sales adjusted adverse drug reaction rates are usually compared in order to be able to take drug exposure into account. Here we review the so-called arithmetic and some statistical procedures which could form the basis for an alert system. The advantages and disadvantages of each of these methods are discussed. The importance of data requirements and the problems which arise when using an alert system are pointed out and then clarified with the help of the example of diphtheria/tetanus vaccine.Keywords
This publication has 9 references indexed in Scilit:
- A surveillance system based on a short memory schemeStatistics in Medicine, 1989
- An analysis of disease surveillance data that uses the geographic locations of the reporting unitsStatistics in Medicine, 1989
- Analysis of surveillance data with poisson regression: A case studyStatistics in Medicine, 1989
- A statistical methodology for postmarketing surveillance of adverse drug reaction reportsStatistics in Medicine, 1988
- Comparison of two statistical techniques for the surveillance of birth defects through a monte carlo simulationStatistics in Medicine, 1984
- The detection of adverse reactions to therapeutic drugsStatistics in Medicine, 1982
- Post-marketing surveillance: how many patients?Trends in Pharmacological Sciences, 1981
- The Use of Cumulative Sums for Sampling Inspection SchemesJournal of the Royal Statistical Society Series C: Applied Statistics, 1962
- CONTINUOUS INSPECTION SCHEMESBiometrika, 1954